In our study, abnormal hypermethylation of promoter CpG dinucleotides of the MMP2, MMP23B, MMP24, MMP25, and MMP28 was associated with HER2-positive tumor status, and, to a different extent, with CpG island hypermethylated epigenomic BC subtype. The gene discussed is MMP2; the disease is breast cancer.